Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Sumatriptan succinate - Generic Drug Details

« Back to Dashboard

What are the generic sources for sumatriptan succinate and what is the scope of sumatriptan succinate freedom to operate?

Sumatriptan succinate
is the generic ingredient in eight branded drugs marketed by Teva Pharms Usa, Injectalia, Sagent Strides, Teva Parenteral, Antares Pharma Inc, Mylan Labs Ltd, West-ward Pharms Int, Dr Reddys Labs Ltd, Aurobindo Pharma, Par Pharm, Glaxosmithkline, Watson Labs, Endo Ventures Ltd, Fresenius Kabi Usa, Teva, Sagent Agila, Roxane, Mylan, Dr Reddys Labs Inc, Sun Pharm Inds Ltd, Aurobindo Pharma Ltd, Sun Pharma Global, Apotex Inc, Sandoz Inc, Par Sterile Products, Sandoz, Meridian Medcl, Teva Branded Pharm, Hikma Farmaceutica, Orchid Hlthcare, Wockhardt, Sun Pharm Inds, Hikma Pharms, and Avanir Pharms, and is included in thirty-nine NDAs. There are thirty-six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Sumatriptan succinate has four hundred and twenty-eight patent family members in thirty-seven countries.

There are twenty-three drug master file entries for sumatriptan succinate. Forty-seven suppliers are listed for this compound. There are five tentative approvals for this compound.

Summary for Generic Name: sumatriptan succinate

Drug Master File Entries: see list23
Suppliers / Packagers: see list47
Bulk Api Vendors: see list66
Clinical Trials: see list81
Patent Applications: see list1,723
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sumatriptan succinate at DailyMed

Pharmacology for Ingredient: sumatriptan succinate

Tentative approvals for SUMATRIPTAN SUCCINATE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 25MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 100MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 50MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
sumatriptan succinate
TABLET;ORAL020132-003Jun 1, 1995ABRXYesNo► Subscribe► Subscribe
Avanir Pharms
sumatriptan succinate
POWDER;INHALATION206099-001Jan 27, 2016RXYesYes8,327,844► Subscribe ► Subscribe
Fresenius Kabi Usa
sumatriptan succinate
INJECTABLE;SUBCUTANEOUS079242-001Mar 2, 2009APRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
sumatriptan succinate
SOLUTION;SUBCUTANEOUS208223-001Jan 28, 2016RXNoNo► Subscribe► Subscribe
Avanir Pharms
sumatriptan succinate
POWDER;INHALATION206099-001Jan 27, 2016RXYesYes8,978,647► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus